Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality?

Table 1 Baseline characteristics of patients

Variables	Whole group, n = 261	Doubase C, n = 138	HCQ-AZI, n = 123	P value
Age	41.0 ± 14.8	40.5 ± 15.3	41.5 ± 14.2	0.581
Men/women	137/134	64/74	73/50	0.036
BMI	26.1 ± 5.4	26.4 ± 5.7	25.6 ± 5.0	0.249
O2pSa	96.9 ± 2.0	97.0 ± 1.7	96.9 ± 2.3	0.449
Hypertension	29 (11.1)	18 (13.0)	11 (8.9)	0.569
Diabetes	9 (3.4)	7 (5.1)	2 (1.6)	0.197
HIV	1 (0.4)	1 (0.7)	0	0.386
Asthma	6 (2.3)	3 (2.2)	3 (2.4)	0.744
Tuberculosis	1 (0.4)	1 (0.7)	0	0.383
Hemoglobin (g/dL)	13 ± 3	13.7 ± 3.2	13.5 ± 2.2	0.673
Creatinine (mg/dL)	0.97 ± 0.30	0.96 ± 0.31	0.99 ± 0.25	0.420
ALAT (UI/L)	25 ± 16	23 ± 14	27 ± 18	0.064
ASAT (UI/L)	28 ±12	29 ± 14	26 ± 11	0.141
K+ (mmol/L)	4.2 ± 2.0	3.9 ± 1.0	3.8 ± 0.11	0.167
Ca2+ (meq/L)	1.17 ± 0.11	1.15 ± 0.11	1.18 ± 0.11	0.430

The results are presented as means and standard deviations or as absolute frequencies (percentages). BMI: Body mass index; HIV: Human immunodeficiency virus; ALAT: Alanine aminotransferase; ASAT: Aspartate aminotransferase; HCQ-AZI: Hydroxychloriquine and azithromycin.